Yanlong Liu

Title: Yanlong Liu: Innovator in Pharmaceutical Chemistry

Introduction

Yanlong Liu is a prominent inventor based in Lianyungang, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of selective BCL-2 inhibitors. His work is crucial in the fight against cancers related to anti-apoptotic proteins.

Latest Patents

Yanlong Liu holds a patent for a crystal of a trifluoromethyl/chloro disubstituted sulfonamide selective BCL-2 inhibitor. This invention is specifically related to a crystal of a compound of formula I, a preparation method therefor, and its use in preventing and treating diseases associated with the BCL-2 protein, such as various forms of cancer. He has 1 patent to his name.

Career Highlights

Liu is affiliated with Chia Tai Tianqing Pharmaceutical Group Co., Ltd., where he continues to innovate and contribute to the pharmaceutical industry. His expertise in the development of targeted therapies has positioned him as a key figure in his field.

Collaborations

Throughout his career, Yanlong Liu has collaborated with notable colleagues, including Zhilin Chen and Chenghui Lu. These partnerships have enhanced his research and development efforts, leading to advancements in cancer treatment.

Conclusion

Yanlong Liu's work in developing selective BCL-2 inhibitors represents a significant advancement in cancer therapy. His contributions to pharmaceutical chemistry are invaluable, and his ongoing research promises to impact the future of cancer treatment positively.